Navigation Links
Intarcia Therapeutics Announces Upcoming Presentation at 34th Annual J.P. Morgan Healthcare Conference
Date:1/7/2016

BOSTON, Jan. 7, 2016 /PRNewswire/ -- Intarcia Therapeutics, Inc. today announced that Chairman, President and CEO Kurt Graves will present a Company overview at 9:00 am Pacific Time on Monday, January 11th, at the J.P. Morgan 34th Annual Healthcare Conference. The presentation will be given in the Elizabethan Meeting Room (C & D) at the Westin St. Francis Hotel, San Francisco, CA.

About Intarcia Therapeutics

Intarcia Therapeutics, Inc. is a biopharmaceutical company developing novel therapies to enhance treatment outcomes by optimizing and improving the efficacy, continuous administration for better adherence rates over time, and improved tolerability of drug therapies. Delivering medicines just once or twice yearly in Intarcia's proprietary technologies has the potential to improve efficacy as well as patient adherence and compliance, which is very poor in most chronic diseases. Intarcia's drug development expertise and competitive edge are demonstrated by its abilities to stabilize proteins, peptides and antibody fragments at above-body temperatures for long periods of time and to deliver them in a precise and consistent manner over the course of a full year. Intarcia has nearly completed conducting its Phase 3-stage development program for type 2 diabetes. It consisted of four separate clinical trials. The results of those trials are now being prepared for filings. Intarcia continues to conduct research and development, utilizing its platform technology, to treat other chronic serious disorders in the field of diabetes, obesity and autoimmune disorders. For more information on the Company, please visit http://www.intarcia.com.

Logo - http://photos.prnewswire.com/prnh/20050301/SFTU126LOGO

 


'/>"/>
SOURCE Intarcia Therapeutics, Inc.
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Intarcia Announces New Top-Line Phase 3 Results For Investigational Therapy ITCA 650 In Type 2 Diabetes
2. Intarcia Announces Presentations At ADA Of Two Successful FREEDOM Phase 3 Trials For ITCA 650 -- A GLP-1 RA For Type 2 Diabetes
3. Intarcia To Announce Key ITCA 650 Phase 3 Findings And Other Data Presentations At Upcoming 75th Scientific Sessions of the American Diabetes Association In Boston
4. Intarcia Exercises Re-Opener For Its Recently Closed Royalty / Equity Convert Financing - Raising Total To $300 Million
5. Intarcia Named To "CNBC Disruptor 50" List: One Of Only Two Biopharma Companies Named
6. Intarcia Names Top Commercial Expert Michael Williams As COO; Will Chair Commercial Committee And Lead ITCA 650 Launch In U.S.
7. Intarcia Appoints James P. Brady Vice President, Human Resources
8. Intarcia Therapeutics Closes Novel $225 Million Synthetic Royalty Financing With Equity Conversion Option At $5.5 Billion Valuation
9. Intarcia And Numab Sign Multi-Asset Collaboration To Develop Once-Yearly Therapies In Diabetes, Obesity, and Autoimmune Indications
10. Intarcia Announces Two Positive Phase 3 Trials for ITCA 650 in Type 2 Diabetes: FREEDOM-1 and FREEDOM-1 High Baseline (HBL) Study Results
11. Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2020)... ... 2020 , ... Cano Health, LLC, a leading population health ... Antonio is happy to announce that it has selected Tejano musician Jay Perez ... will serve as community advisor, advertising talent, and creative consultant for Cano Health, ...
(Date:8/27/2020)... ... 2020 , ... InfoMC, a leading provider of cloud-based healthcare ... System and Organizational Controls (SOC) 1® Type 2 and SOC 2® Type 2 ... achievements reflect their long-standing commitment to privacy, security, and risk management, while giving ...
(Date:8/27/2020)... ... August 27, 2020 , ... Bleep LLC, maker of the DreamPort mask-less CPAP ... the company’s new spokesperson. , “In my line of work, a good night of ... Bleep DreamPort it was a Bleeping no brainer for me,” said Jensen. “From the ...
Breaking Medicine Technology:
(Date:8/28/2020)... , ... August 28, 2020 , ... ... & CEO Craig Mandeville was named an Entrepreneur Of The Year® 2020 Florida ... honors entrepreneurial business leaders whose ambitions deliver innovation, growth and prosperity as they ...
(Date:8/28/2020)... , ... August 28, 2020 , ... ... one-year subscription to a customized Lighthouse Health & Wellness mobile app and web-portal. ... this project. Motorola Solutions Foundation awards grants each year to organizations, such as ...
(Date:8/28/2020)... ... , ... Integrated Viral Protection (IVP Air) today announced that the ... breakthrough Mobile Biodefense Indoor Air Protection System that is the first system designed and ... reopen equipped with the filtration system on September 8th. , The IVP Air ...
(Date:8/28/2020)... ... August 28, 2020 , ... ... strongly suggest that obese individuals are at an increased risk of developing severe ... likely to catch COVID-19; however, because the same organ systems that the coronavirus ...
(Date:8/27/2020)... ... 27, 2020 , ... The team at Sikara MedSpa is ... retreat. The practice is centered on results and providing the ultimate patient experience ... to be a sanctuary for total body renewal and aesthetic revitalization, Sikara Medspa ...
Breaking Medicine News(10 mins):